While higher tau tracer uptake in neocortical regions and thus higher cut-points are associated with younger age-of-onset and non-amnestic clinical presentations of AD patients, greater medial temporal lobe vulnerability is seen in older patients with amnestic symptoms such as in the ADNI sample (e.g., [14]). This evidence concerns the gene MAPT and Alzheimer disease.